Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

15 Drugs in Development

15 Drugs in Development

DIGITAL CONTENT

3 NEWS #PharmaBuzz

media
3 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

15DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 2090064-66-5, Vebicorvir [inn], Vebicorvir [usan], Abi-h0731, 16f6055smg, 11-oxo-n-((2-(trifluoromethyl)thiazol-5-yl)methyl)-10,11-dihydrodibenzo[b,f][1,4]thiazepine-8-carboxamide 5,5-dioxide

Molecular Formula

C₁₉H₁₂F₃N₃O₄S₂

Molecular Weight

467.4 g/mol

InChI Key

LBJVBJYMZKEREY-UHFFFAOYSA-N

FDA UNII

16F6055SMG

1 2D Structure

Vebicorvir

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

6,11,11-trioxo-N-[[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-5H-benzo[b][1,4]benzothiazepine-3-carboxamide

2.1.2 InChI

InChI=1S/C19H12F3N3O4S2/c20-19(21,22)18-24-9-11(30-18)8-23-16(26)10-5-6-15-13(7-10)25-17(27)12-3-1-2-4-14(12)31(15,28)29/h1-7,9H,8H2,(H,23,26)(H,25,27)

2.1.3 InChI Key

LBJVBJYMZKEREY-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1=CC=C2C(=C1)C(=O)NC3=C(S2(=O)=O)C=CC(=C3)C(=O)NCC4=CN=C(S4)C(F)(F)F

2.2 Other Identifiers

2.2.1 UNII

16F6055SMG

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. 2090064-66-5

2. Vebicorvir [inn]

3. Vebicorvir [usan]

4. Abi-h0731

5. 16f6055smg

6. 11-oxo-n-((2-(trifluoromethyl)thiazol-5-yl)methyl)-10,11-dihydrodibenzo[b,f][1,4]thiazepine-8-carboxamide 5,5-dioxide

7. 5,5,11-trioxo-10,11-dihydro-5h-dibenzo[b,f][1,4]thiazepine-8-carboxylic Acid (2-trifluoromethyl-thiazol-5-ylmethyl)-amide

8. Dibenzo(b,f)(1,4)thiazepine-8-carboxamide, 10,11-dihydro-11-oxo-n-((2-(trifluoromethyl)-5-thiazolyl)methyl)-, 5,5-dioxide

9. Vebicorvir [who-dd]

10. Unii-16f6055smg

11. Chembl4650324

12. Schembl21250344

13. Who 11201

14. Hy-109195

15. Cs-0119137

16. 11-oxo-n-((2-(trifluoromethyl)thiazol-5-yl)methyl)-10,11-dihydrodibenzo[b,f][1,4]thiazepine-8-carboxamide5,5-dioxide

17. 5,5,11-trioxo-n-((2-(trifluoromethyl)-1,3-thiazol-5-yl)methyl)-10,11-dihydro-5h- 5.lambda.6-dibenzo(b,f)(1,4)thiazepine-8-carboxamide

18. 6,11,11-trioxo-n-[[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-5h-benzo[b][1,4]benzothiazepine-3-carboxamide

2.4 Create Date

2019-11-02

3 Chemical and Physical Properties

Molecular Formula	C₁₉H₁₂F₃N₃O₄S₂
Molecular Weight	467.4 g/mol
XLogP3	2.4
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	9
Rotatable Bond Count	3
Exact Mass	467.02213271 g/mol
Monoisotopic Mass	467.02213271 g/mol
Topological Polar Surface Area	142 Å²
Heavy Atom Count	31
Formal Charge	0
Complexity	817
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1